Marked Improvement with Sildenafil in a Patient with Idiopathic Pulmonary Arterial Hypertension Unresponsive to Beraprost and Sarpogrelate

Hiroaki Kawano; Hideyori Sengyoku; Osami Satoh; Shigetoshi Urabe; Yuji Koide; Katsusuke Yano

doi:10.2169/internalmedicine.46.1848

CASE REPORTS

Marked Improvement with Sildenafil in a Patient with Idiopathic Pulmonary Arterial Hypertension Unresponsive to Beraprost and Sarpogrelate

Hiroaki Kawano, Hideyori Sengyoku, Osami Satoh, Shigetoshi Urabe, Yuji Koide, Katsusuke Yano

Author information

Keywords: beraprost, saprogrelate, sildenafil, pulmonary hypertension, treatment

JOURNAL OPEN ACCESS

2007 Volume 46 Issue 12 Pages 893-898

DOI https://doi.org/10.2169/internalmedicine.46.1848

Details

Abstract

We report a 16-year-old man with severe heart failure due to idiopathic pulmonary arterial hypertension (IPAH). The patient was initially treated with a combination of beraprost, a prostacyclin analog, and sarpogrelate, a serotonin receptor inhibitor. However, he was unresponsive to the treatment. We then changed the treatment to sildenafil, and his condition dramatically improved. Sildenafil has an immediate pulmonary vasodilator effect in patients already receiving vasodilators for IPAH.

Corresponding author

Register with J-STAGE for free!